back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-06-12 16:41 Tx date 2025-06-11 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Starr, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$154,000
+200,000 vol $0.77 each |
300,000 | |
| Filed 2022-12-09 09:33 Tx date 2022-12-08 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Starr, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
100,000 | |
| Filed 2022-12-09 09:17 Tx date 2022-03-31 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Starr, Christopher
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-07 13:04 Tx date 2022-03-31 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Starr, Christopher
4 - Director of Issuer
Direct Ownership
|
Options Private Third Party Options
50 - Grant of options
|
$489,999
+1,400,000 vol $0.35 each |
1,400,000 | |
| Filed 2022-04-07 13:00 Tx date 2022-03-31 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Starr, Christopher
4 - Director of Issuer
Direct Ownership
|
Options Private Third Party Options
00 - Opening Balance-Initial SEDI Report
|